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Background
Based on the kindling hypothesis of PTSD this double
blind clinical trial assesses clinical response to Topiramate
as a potential treatment.
Materials and methods
Sixty seven combat veterans with PTSD (30–50 years old
S; 39.5 ± 4.19) randomly assigned in a double blind
design. They were treated for 12 weeks with Topiramate (n
= 33). Measures used in monthly assessments during 3
months of treatment included the clinician-Administered
PTSD Scale (CAPS). Paired T-student Friedman and Will-
coxon were used to data analysis.
Results
Three patients were withdrawn from study because of
Topiramate side effect. In remainders the mean score of
Topiramate group in the first visit was 50.70 ± 7.7 and the
mean score of placebo group was 48.9 ± 9.13. After finish-
ing the treatment period the mean score of the the topira-
mate group was 32.75 ± 8.8. The analysis of these scores
showed a significant difference between the groups(p =
0.00). In details: Frequency and intensity of reexperience
criteria (intrusive memory nightmare and flash back)
sleep problem irritability and anger and frequency of dif-
ficulty to recall and intensity of startle reaction in Topira-
mate group was significantly less than placebo group (p <
0.05).
Discussion
The results of current study suggest that Topiramate is a
safe well tolerate and significantly effective treatment for
PTSD.
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